Red Light Therapy for PTSD and Brain Injury | Ep. 16 with Grey Team

Red Light Therapy for PTSD and Brain Injury | Ep. 16 with Grey Team

Veteran mental health, PTSD, traumatic brain injury, photobiomodulation, red light therapy, near-infrared light, suicide prevention, brain inflammation, integrative recovery. This episode of the Light Medicine Podcast looks at how one organization uses light-based therapy to help veterans recover from PTSD and brain injury. Cary Reichbach is a US Army veteran and the founder of Grey Team, a Florida nonprofit that has spent 10 years building a no-cost, 90-day recovery program for veterans facing PTSD, traumatic brain injury, and the difficult transition back to civilian life. The program pairs photobiomodulation with a wider stack of recovery technologies. In this conversation with Robert Weber, Cary shares the mission behind Grey Team, why he believes brain inflammation sits at the center of so much veteran suffering, and what a decade of using light therapy has shown him. If you or a veteran you know is struggling, the 988 Suicide and Crisis Lifeline is available 24 hours a day in the US. Call or text 988, then press 1 for the Veterans Crisis Line, or text 838255. In this episode, you will find: ✅ Why leaving service disrupts sleep, circadian rhythm, and identity ✅ How Cary sees brain inflammation in PTSD and TBI ✅ Inside Grey Team's 90-day program and its technologies ✅ The problem of leaving service on multiple prescriptions ✅ Photobiomodulation and the WeberBrain helmet in practice ✅ How Cary weighs light therapy for tolerability ✅ A veteran's story of coming back from a crisis point ✅ Why PTSD and brain injury reach beyond the military ✅ How Grey Team is funded and supported Whether you are a veteran, a family member, a clinician, or someone working in mental health, this conversation offers an honest look at a different approach to recovery. Connect with Grey Team: 🌐 greyteam.org ⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️ ⚡️ Connect with us: 🌐 webermedical.com 📧 info@webermedical.com 📸 instagram.com/webermedical 🔵 facebook.com/WeberMedicalGmbH 💼 linkedin.com/company/webermedical ⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️ 🎬 WATCH OUR OTHER VIDEOS: ▶️ Methylene Blue, IV Light, and What Most Get Wrong ▶️ Lasers Inside The Body: Ultrasound-Guided Therapy ▶️ Light Medicine and the Future of Clinical Research 👍 If this resonated, please Like, Comment, and Subscribe for more conversations on light therapy, brain health, and integrative recovery. #Photobiomodulation #Veterans #PTSD #TraumaticBrainInjury #MentalHealth #SuicidePrevention #RedLightTherapy #BrainHealth #GreyTeam #LightMedicinePodcast

Methylene Blue, IV Light, and What Most Get Wrong | Ep. 15 with Dr. Paul Anderson

Dr. Paul Anderson has spent more than 30 years practicing, teaching, and researching at the edge of naturopathic and integrative medicine. Half his patients have advanced cancer, the other half advanced chronic illness, which is how he came to combine intravenous nutraceutical and botanical therapies with laser light, drawing on a background in optics from before his medical career. In this conversation with Robert Weber, he breaks down how photobiomodulation changes what an IV infusion can do, why matching the wavelength to the molecule matters, and where light therapy fits in serious, complex cases. In this episode: How light changes an infusion: why photoactivating an agent can let a smaller dose do the work of a larger one, and why larger plant-derived molecules respond so well to light. Match the light to the molecule: the difference between running every color at once and tuning the wavelength to each agent, and the absorption chart Dr. Anderson built to do it. Who responds fastest: why patients with chronic infections and immune dysregulation often notice changes sooner than cancer patients. Artesunate and high-dose vitamin C: how Anderson uses two light-responsive agents in chronic infection and coinfection cases. Light without an endolaser: how oral botanicals reaching steady state can be photoactivated externally, including at home. Methylene blue, honestly: where it earns its place, why source and quality matter more than most people realize, and why he reaches for what the body already makes first. Hyperbaric oxygen and light: how stacking the two changes the downstream effect. Regeneration and the terrain: why a healthier body regenerates better, and why the mitochondria are the real target. The nutraceuticals behind brain repair: phosphatidylcholine, alpha-lipoic acid, NAD, IV curcumin, and Boswellia. Light and cancer: why the old fear that light feeds tumors is being re-examined, and what the research does and does not yet establish. About Dr. Paul Anderson: Dr. Paul Anderson is a naturopathic medical doctor with more than 30 years in practice, teaching, and research, focused on advanced cancer and complex chronic illness. He leads the AAMP (Advanced Applications in Medical Practice) conference series, is the author of several books, and runs a medical-education YouTube channel with hundreds of videos. He has lectured at ISLA conferences internationally. Connect with Dr. Paul Anderson: Website, with links to his books, videos, and conference: DrANow.com [http://DrANow.com] Connect with Weber Medical: Website: webermedical.com [http://webermedical.com] LinkedIn: linkedin.com/company/webermedical Disclaimer: This podcast is for educational purposes only and does not constitute medical advice. The therapies discussed are used in specialized clinical settings. Consult a qualified healthcare professional before beginning any new treatment. #Photobiomodulation #IVTherapy #LaserTherapy #IntegrativeMedicine #NaturopathicMedicine #LightMedicine #IntravenousLaser #MethyleneBlue #IntegrativeOncology #MitochondrialHealth #FunctionalMedicine #WeberMedical

Red Light Therapy for the Brain | Ep. 14 with Robert Weber

Robert Weber has worked with medical laser technology for more than 20 years. In this first solo episode of the Light Medicine Podcast, he walks through the transcranial photobiomodulation device his team spent two years building, the WeberBrain helmet, and what red and near-infrared light can and cannot do once it reaches brain tissue. This is a working overview, not a sales pitch. Robert covers the mechanism, the engineering decisions behind the device, the early observations coming back from clinics and conferences, the dose finding that caught his team off guard, and the protocols his research partner Martin Junggebauer wrote for the most common brain conditions. In this episode: What the helmet does: Red and near-infrared light, delivered by focused lasers through the skull to reach brain tissue and act on the mitochondria, cerebral blood flow, and inflammation. For the deeper mechanism, Robert points to Dr. Hamblin's department at Harvard and his earlier episode with Martin Junggebauer. Laser versus LED: Why coherent, focused laser light reaches deeper than the spread light of an LED, the lens system that focuses each beam, and the light fingers that pass through hair to sit directly on the skull. From 12 lasers to 700: The path from early multi-channel laser devices used for stroke recovery, through a first-generation helmet with 320 infrared LEDs, to the current clinical device carrying almost 700 real laser diodes at a total output near 14 watts. Three wavelengths, three depths: Why the device runs 680nm in the red range plus 808nm and 1064nm in the infrared, and how different wavelengths reach different layers of tissue. Clinical model versus home model: The roughly 700-laser pro device for clinics and the 228-diode home model, and why progressive conditions like dementia and Parkinson's call for an ongoing approach rather than a single course. What clinics are reporting so far: Clarity and alertness after one or two sessions, a calmer state at 10 hertz, and the observations Robert is honest about not yet explaining, including reports of sharper eyesight and clearer sinuses. Observations, not conclusions. The dose finding: Dr. Leonard Kaplan's testing with ViewMind eye-tracking showed not every patient improved. Too much power for too long looked like overstimulation. The gains in processing speed and working memory showed up when the dose was pulled back to the right window. More was not better. One photodynamic case: A patient who presented with 40 brain lesions from metastatic disease. Robert walks through the before and after imaging following a five-day protocol that paired a photosensitizer with the helmet, and stays clear about what a single case can and cannot establish. The protocol book: The starting guidelines Martin Junggebauer built, beginning simple at 20 minutes and continuous wave, with separate recommendations for Parkinson's, traumatic brain injury, depression, anxiety, and autism. Performance, prevention, and sleep: Where the helmet fits for focus, reaction time, mental recovery, and sleep, the first athlete trials now starting, and why Robert uses the home model on himself every day. About Robert Weber: Robert Weber is the founder and managing director of Weber Medical Systems and head of research at ISLA, the International Society for Medical Laser Applications. He has worked in medical laser therapy for more than 20 years and hosts the Light Medicine Podcast. His work centers on photobiomodulation and its clinical applications across pain, recovery, inflammation, and brain health. Connect with Weber Medical: Website: webermedical.com [http://webermedical.com] LinkedIn: linkedin.com/company/webermedical WeberBrain early access: form.typeform.com/to/swd2jebc Disclaimer: This podcast is for educational purposes only and does not constitute medical advice. The clinical observations and individual cases described are not proof of efficacy. Consult a qualified healthcare professional before beginning any new treatment. #RedLightTherapy #Photobiomodulation #BrainHealth #TranscranialPhotobiomodulation #NearInfrared #WeberBrain #LightMedicine #CognitiveHealth #Neurodegeneration #Dementia #Parkinsons #LaserTherapy #PhotodynamicTherapy #WeberMedical

Sono-Photodynamic Therapy for Cancer | Ep. 13 with Dr. Tony Jimenez

Dr. Tony Jimenez has been treating cancer patients with sono-photodynamic therapy since 2002. He is the founder of Hope for Cancer Treatment Centers, with clinics in Tijuana and Cancun serving patients from over 70 countries across six continents. His approach is grounded in seven principles of non-toxic cancer therapy, and sono-photodynamic therapy sits at the foundation of all of them. This episode covers the mechanisms, the clinical data, the patient cases, and the protocols Dr. Tony has refined over more than two decades in integrative oncology. In this episode: How Dr. Tony got into this field: His father was diagnosed with prostate cancer in his early 60s, declined conventional treatment after one session, and asked his son for help. That call changed everything. What sonodynamic therapy actually is: How ultrasound combined with a sensitizer produces cavitations and reactive oxygen species that target abnormal cells without harming healthy tissue. Why patients no longer need to sit in bathtubs, and what the current protocol looks like in clinical practice. The trifecta: Energy source, sensitizer, and oxygen. Why all three must be present for sono-photodynamic therapy to perform. How stacking hyperbaric oxygen, methylene blue, and light simultaneously changes the outcome. Circulating tumor cells: Why Dr. Tony believes sono-photodynamic therapy targets the cells that escape a primary tumor and travel through the bloodstream. The cells chemo and radiation do not kill. The cells that eventually land in bone, lung, liver, or brain. After any surgery, do this: What Dr. Wang, the oncologist in China who has been treating cancer for over 50 years, told Dr. Tony at dinner in July 2025. The case for following every ectomy with sonodynamic therapy. The clinical data: A one-year longitudinal study across seven cancer types compared against National Cancer Institute SEER data. Quality of life improvements of 83 to 100 percent in the first three weeks of treatment.  Five-year survival in pancreatic cancer at 35.6 percent, against a conventional benchmark of 2.5 to 5 percent. Kate's case: Diagnosed with a lung tumor, liver metastasis, and cancer in 70 percent of her bones. Given six months to live in Australia. Lung tumor and all liver metastasis cleared quickly. All bone lesions clear in 359 days. Four and a half years later, a recurrence including 10 brain tumors with no neurological symptoms. Cleared again. Scan last week: all clear. Brain tumors and the Weber helmet: After one week of treatment combining the new Weber laser helmet with sonodynamic therapy, nearly all brain metastases disappeared in a recent patient. What that means for the future of treating brain tumors non-invasively. Doing it on yourself: Why Dr. Tony only prescribes therapies he would take himself. The poll that found 84 percent of conventional oncologists would not give themselves what they give their patients. What his own prevention stack looks like. About Dr. Tony Jimenez: Dr. Tony Jimenez is the founder and chief medical officer of Hope for Cancer Treatment Centers in Tijuana and Cancun, Mexico. He has been practicing integrative oncology since 2000 and using sono-photodynamic therapy in clinical practice since 2002. He is the author of Hope for Cancer and Cancer Outsmarted, with a third book on emotional trauma and healing due in late 2026. He is a regular speaker at the International Photodynamic Association Congress and at ISLA conferences worldwide. Connect with Dr. Tony Jimenez: Website: hopeforcancer.com Connect with Weber Medical: Website: webermedical.com LinkedIn: linkedin.com/company/webermedical Disclaimer: This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before beginning any new treatment.

The Truth About IV Laser Therapy | Ep. 12 with Dr. Michael Ellenburg

In this episode, Robert sits down with Dr. Michael Ellenburg, a naturopathic doctor from Anchorage, Alaska with nearly nine years of IV laser and photobiomodulation experience in clinical practice.  Dr. Ellenburg is one of the most experienced PBM practitioners in the United States, treating chronic infections, cancer patients, joint conditions, and complex cases where conventional options have plateaued. He brings a rare combination of deep clinical experience and mechanistic understanding to the conversation, and shares protocols, combinations, and real patient outcomes that practitioners can take directly into their own clinics. In this episode, we cover: How IV Laser Works at a Cellular Level: A deep dive into the mechanisms behind intravenous photobiomodulation, how different wavelengths affect red blood cells, white blood cells, and platelets, why blood viscosity changes, and how mitochondrial water channels play a role in ATP production. Wavelength Selection in Practice: How Dr. Ellenburg designs protocols for specific conditions, why he uses blue and UV for acute infections, skips red for certain inflammatory conditions like rheumatoid arthritis, and why green is gaining clinical relevance for stem cell release from bone marrow. Laser and Cancer Care: How IV laser is being used as an adjunct to chemotherapy and immunotherapy, reducing the need for growth factor injections, decreasing transfusion requirements, and improving patient tolerance of standard oncological treatment. PRP and Light Activation: Why Dr. Ellenburg has never done PRP without laser, and the clinical outcomes in knee and shoulder cases that, in his words, sometimes astonish him. How priming patients with IV laser in the week before a PRP procedure amplifies results. Combining Laser with Ozone, Stem Cells, and Exosomes: A practical look at how IV laser integrates with other advanced therapies, and what Dr. Ellenburg learned from Dr. Herskowitz's lecture on exosomes and laser at the ISLA San Diego conference. Chronic Kidney Disease: A real patient case where creatinine was brought from 2.5 back under 1 using IV laser and methylene blue alone — and the ongoing protocol for a family member facing dialysis. Transcranial PBM and Cognitive Function: Clinical experience with the Weber infrared helmet, the surprising data on IV laser improving cognitive outcomes without transcranial application, and why the combination of both is the most promising approach. The Herxheimer Difference: Why switching from ultraviolet blood irradiation to IV laser dramatically reduced die-off reactions in infection patients, and what that means for patient compliance and outcomes. About the Guest: Dr. Michael Ellenburg is a naturopathic doctor and owner of the Ellenburg Center for Natural Medicine in Anchorage, Alaska. A graduate of Bastyr University, he has been practicing integrative medicine since 2002 and has used IV laser therapy in clinical practice since 2017. He is a regular speaker at ISLA conferences and one of the leading voices on IV photobiomodulation mechanisms in the United States. He also hosts a live health radio show on 1080 AM and 95.1 FM KOAN in Alaska. Connect with Dr. Ellenburg: LinkedIn: https://www.linkedin.com/in/dr-michael-ellenburg-87ab6ba/ Website: www.1080koan.com Connect with Weber Medical: Website: https://www.webermedical.com LinkedIn: / webermedical Disclaimer: The content of this podcast is for educational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new treatment.